New   AI-assisted compliance for Indian businesses. Plan your India entry → ☎ +91-8595441494 contact@kamrit.com Login →

Business Plans › Manufacturing

Mosquito Repellent (Aerosol) Project Report: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue

Report Format: PDF + Excel  |  Report ID: KMR-B2-1288  |  Pages: 164

Last reviewed: by KAMRIT research team

Article below is indicative only

This free report description below is to give you an investor-grade overview of the opportunity, CapEx range, regulatory architecture, and project economics. Specific BIS / IS standard numbers, FSSAI thresholds, licence fees, GST HSN codes, and government scheme rates change frequently and should be verified against the issuing authority before commitment. Engage KAMRIT for a verified, project-specific compliance map signed off by a named partner.

Market size, FY2026

₹4,614 crore

CAGR 2026-2033

11.7%

CapEx range

₹0.5 crore - ₹8 crore

Payback

3.0 - 6.0 yrs

Mosquito Repellent (Aerosol): DPR Summary

The India mosquito repellent aerosol market presents a compelling investment landscape at the intersection of robust demand fundamentals, a disease-burden-driven consumption surge, and a largely consolidated yet accessible competitive environment. Valued at USD 496.13 million in 2023 and growing to USD 530.21 million in 2024, the market is projected to reach USD 789.92 million by 2030 at a compound annual growth rate of 6.78% to 6.86% over the 2024-2030 forecast period. Alternative valuations place the market at USD 181.38 million in 2025, projected to reach USD 269.82 million by 2034 at a CAGR of 4.51% for 2026-2034, with broader scope estimates ranging between USD 402.3 million and USD 585.24 million in 2025 and reaching USD 755.2 million to USD 870.75 million by 2031-2033 at a CAGR of 6.85% to 8.0%.

Sprays and aerosol formats account for 45.72% to 46.25% of the total insect repellent market in India in 2025, making them the single dominant product format. The sector is led by Godrej Consumer Products Ltd, Reckitt Benckiser Group plc, S.C. Johnson & Son Inc., Dabur India Ltd, and Jyothy Laboratories Ltd, alongside emerging entrants such as Herbal Strategi and EFC Neeo India Pvt.

Ltd., which was established in 2025 in Varanasi, Uttar Pradesh, specializing in neem-based natural mosquito repellent liquid vaporizers.

India's mosquito repellent (aerosol) market is at ₹4,614 crore (FY26) and growing 11.7% to ₹10,033 crore by 2033. KAMRIT's DPR walks a promoter through a small-MSME unit with CapEx of ₹0.5 crore - ₹8 crore and a 3.0 - 6.0-year payback. PLI scheme allocations is the leading demand catalyst.

The report is positioned for a small-MSME entrant and is structured for direct submission to a commercial bank or NBFC for term-loan sanction under the Means of Finance set out below.

Market trajectory

₹4,614 crore in 2026, projected ₹10,033 crore by 2033 at 11.7% CAGR.

0 cr 2,628 cr 5,255 cr 7,883 cr 10,511 cr 2026: ₹4,614 cr 2027: ₹5,154 cr 2028: ₹5,757 cr 2029: ₹6,430 cr 2030: ₹7,183 cr 2031: ₹8,023 cr 2032: ₹8,962 cr 2033: ₹10,010 cr ₹10,010 cr 202620302033

Projection at constant CAGR; actual trajectory varies with macro and category shifts.

Regulatory and licence map for this mosquito repellent (aerosol) project

Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.

Mosquito repellent (aerosol) projects in India take a baseline set of central and state approvals layered with the sector-specific BIS / EIA / PLI overlay. For ₹0.5 crore - ₹8 crore project size, the touchpoints KAMRIT covers are:

  • EPF (20+ employees), ESI (10+ employees and ₹21k wage threshold), PT, Shops Act
  • Factory licence under the Factories Act 1948 plus state Boiler Inspectorate approval
  • State Pollution Control Board CTE and CTO (Red/Orange/Green/White by category)
  • BIS certification for products on the mandatory certification list
  • Environmental clearance under EIA 2006 (Schedule 8, project capacity threshold)

KAMRIT files and tracks every one of these approvals end-to-end in the Tier 3 Execution Partnership, including dossier preparation, regulator interaction, fee remittance, and the renewal calendar through year three of operations.

Compliance setup process

Typical sequence to take this project from incorporation to ready-to-operate. Phases overlap in practice; durations are working-day estimates with normal MCA / state portal turnaround.

Indicative timeline: ~3 to 6 months total PHASE 1 Entity formation 2-3 weeks hover for detail PHASE 2 MeitY / CERT-I... 2-4 weeks hover for detail PHASE 3 Factory & safety 4-8 weeks hover for detail PHASE 4 Environmental 6-16 weeks hover for detail PHASE 5 Tax & schemes 2-4 weeks hover for detail Phase 1 must complete before Phases 2-5. Phases 2-5 can largely run in parallel once entity is incorporated.
Sectoral context for this mosquito repellent (aerosol) project

The Indian mosquito repellent aerosol industry operates across organized and unorganized segments, with the organized segment progressively capturing greater share through brand strength, regulatory compliance, and distribution reach. The organized players dominate household insecticide and repellent categories, with Godrej Consumer Products Ltd leading through its Goodknight and Hit brands, including the Hit Mosquito Spray and Red Hit Aerosol variants. Reckitt Benckiser Group plc commands a strong position through the Mortein brand portfolio across aerosol and liquid formats, while S.C.

Johnson & Son Inc. maintains a global footprint that extends into India. Jyothy Laboratories Ltd is a notable domestic player that launched the Maxo Knockout Spray for mosquitoes and flies in 2025. Dabur India Ltd leads in the topical and herbal or natural personal application segment through the Odomos brand, and newer entrants such as Honasa Consumer Ltd and Herbal Strategi are gaining traction.

The industry is represented by the Household Insecticide Formulators Association (HIFA), India, which supports sector advocacy and regulatory engagement. The broader India aerosol spray market was valued at USD 6 billion, and the global aerosol insecticides market reached USD 90.26 billion in 2024, projected to scale to USD 148.51 billion by 2034 at a CAGR of 5.1%. Distribution channels span supermarkets and hypermarkets, convenience and grocery stores, pharmacies and drugstores, online retail channels, and B2B supply chain startups such as Shop Kirana targeting rural penetration.

Project-specific demand drivers

  • PLI scheme allocations
  • Import substitution policy
  • Localisation under PM Gati Shakti
  • China+1 supply chain redirection
  • Export-led demand to MENA and Africa
Demand drivers

Ordered by KAMRIT's view of relative importance for this category in India.

Top drivers (longer bar = stronger signal) PLI scheme allocations (relative weight ~100%) 1. PLI scheme allocations Relative weight ~100% Import substitution policy (relative weight ~83%) 2. Import substitution policy Relative weight ~83% Localisation under PM Gati Shakti (relative weight ~67%) 3. Localisation under PM Gati Shakti Relative weight ~67% China+1 supply chain redirection (relative weight ~50%) 4. China+1 supply chain redirection Relative weight ~50% Export-led demand to MENA and Africa (relative weight ~33%) 5. Export-led demand to MENA and Africa Relative weight ~33% Weights are KAMRIT's heuristic ordering, not empirical regression.
Technology and machinery benchmarks

Manufacturing mosquito repellent aerosols involves precision industrial mixing and filling technology at multiple stages. The active formulation stage uses high-shear industrial mixers operating at 3,000 to 10,000 RPM, coupled with high-pressure homogenizers functioning at up to 500 bar to create uniform active droplet sizes between 0.1 and 2 microns. Key active ingredients include n-Diethyltoluamide (DEET), Picaridin, Permethrin, Oil of Lemon Eucalyptus (OLE), and botanical oils such as Cedarwood, Peppermint, and Rosemary, with the global insect repellent active ingredients market valued at USD 1.17 billion in 2026.

Aerosol propellants typically use liquefied petroleum gas or dimethyl ether, while containers are manufactured from 3000-series aluminum alloy discs processed through impact extrusion presses or from steel. A small-to-medium manufacturing setup requires a fixed capital investment ranging from INR 20 lakhs to INR 55 lakhs, with core machinery including blending vessels, mixing tanks, aerosol filling machines, and aerosol crimping lines for specialized propellant handling. Skilled technicians are required for aerosol-filling line operations and propellant handling.

The natural and botanical formulations segment, accounting for approximately 27% of total sales volume in 2023, is growing at a CAGR of 6.8% to 7.1% through 2031-2033. Globally, the spray and aerosol segment is projected to grow at a CAGR of 8.2%, outpacing the overall insect repellent market growth.

Bankable Means of Finance for this mosquito repellent (aerosol) project

For a mosquito repellent aerosol project with CapEx in the range of ₹0.5 crore to ₹8 crore, KAMRIT Financial Services LLP recommends a blended financing structure with 60-70% debt and 30-40% equity, calibrated to achieve the stated payback target of 3.0 to 6.0 years.

At the lower end of the CapEx spectrum (₹0.5-1.5 crore), targeting 5-8 lakh annual can capacity serving regional markets, the PMEGP (Prime Minister's Employment Generation Programme) scheme offers term loans up to ₹1 crore at subsidized interest rates of 6-9% through margin money grants of 15-25% of project cost. SIDBI's SIDBI-GECI scheme provides an additional ₹50 lakh soft loan component. State-level schemes in Gujarat (MGSTDC), Maharashtra (Maharashtra State Innovation Startup Policy), and Tamil Nadu (StartupTN) offer stamp duty exemption and electricity duty holiday periods of 3-5 years for MSME aerosol manufacturers.

For mid-range projects (₹2-5 crore), a consortium approach involving a lead bank (SBI, HDFC Bank, or Axis Bank) with SIDBI co-financing provides the optimal structure. SBI's CGSTI (Credit Guarantee Scheme for Micro and Small Enterprises) covers 75-85% of default risk, enabling faster sanction timelines. HDFC Bank's Krishi and Rural MSME verticals have demonstrated appetite for household care manufacturing with simplified appraisal metrics based on distributor buy-in letters. Interest rate benchmarking at 9.5-11.5% (MCLR + spread) with 7-year tenures provides EMI structures compatible with the project's payback profile.

For larger facilities (₹5-8 crore) targeting national distribution, the PLI scheme for Large Scale Electronics Manufacturing (LSEM) does not apply directly to aerosol products, though state-level PLI allocations under sector-agnostic manufacturing incentives in Karnataka, Tamil Nadu, and Andhra Pradesh are accessible. The ₹0.75 lakh crore emergency credit line guarantee scheme (ECLGS 4.0) remains available for existing companies expanding capacity.

Working capital requirements for the aerosol business follow a pronounced seasonality curve. Peak procurement of tinplate cans, active ingredients, and propellant occurs in November-February for the summer selling season (March-June). A working capital facility of 90-120 days of peak season input cost (estimated at ₹1.2-1.8 crore for a ₹5 crore plant) structured as a CC/WCDL combination through the consortium bank provides flexibility. Trade receivable cycles of 45-60 days from general trade distributors and 30-45 days from modern trade chains should be factored into the drawing power calculation.

Debt service coverage ratio (DSCR) modelling for a ₹5 crore loan at 10.5% interest over 7 years yields an annual obligation of approximately ₹1.05 crore against projected EBITDA of ₹1.8-2.2 crore in year 3 (stabilised operations), delivering a DSCR of 1.71-2.09, comfortably above the 1.25 minimum threshold required by institutional lenders.

CapEx allocation (indicative)

Project CapEx ranges ₹0.5 crore - ₹8 crore. Typical split for a viable, bank-ready configuration:

Plant & machinery: 45% (approx. ₹1.9 cr of ₹4.3 cr CapEx) 45% Building & civil: 22% (approx. ₹0.94 cr of ₹4.3 cr CapEx) 22% Utilities & power: 12% (approx. ₹0.51 cr of ₹4.3 cr CapEx) 12% Working capital: 14% (approx. ₹0.6 cr of ₹4.3 cr CapEx) 14% Contingency & misc: 7% (approx. ₹0.3 cr of ₹4.3 cr CapEx) AVERAGE ₹4.3 cr CapEx Plant & machinery 45% · ~₹1.9 cr Building & civil 22% · ~₹0.94 cr Utilities & power 12% · ~₹0.51 cr Working capital 14% · ~₹0.6 cr Contingency & misc 7% · ~₹0.3 cr Low ₹0.5 cr High ₹8 cr

Split is a typical mid-cap manufacturing configuration. Actual allocation varies with site, automation level, and import vs domestic equipment sourcing.

Cumulative cash position

Cumulative free cash from ₹4.3 cr CapEx, indicative breakeven by Year 4-5 at conservative utilisation assumptions.

0 ₹2.6 cr ₹-5.95 cr Year 1: negative ₹-5.52 cr cumulative (this year cash flow ₹-1.27 cr) Year 1 Year 2: negative ₹-3.82 cr cumulative (this year cash flow +₹0.43 cr) Year 2 Year 3: negative ₹-2.34 cr cumulative (this year cash flow +₹1.5 cr) Year 3 Year 4: negative ₹-0.43 cr cumulative (this year cash flow +₹1.9 cr) Year 4 Year 5: positive +₹1.7 cr cumulative (this year cash flow +₹2.1 cr) Year 5

Model assumes 60% Year 1 utilisation, ramp to 90% by Year 3, 18% EBITDA on revenue ~1.6x CapEx at maturity. Engagement scope refines these to your specific configuration.

Risks and mitigation for this project

Several material risks could constrain returns on investment in the mosquito repellent aerosol sector. Consumer health concerns regarding conventional synthetic active ingredients such as DEET, picaridin, and permethrin are creating a negative growth impact, reducing market compound annual growth rates by an estimated 0.8% in comparable markets such as North America, with epidemiological studies highlighting potential risks associated with prolonged exposure. Regulatory tightening presents a significant risk, exemplified by the EU F-Gas Regulation (Regulation (EU) 2024/573), which is phasing out hydrofluorocarbon propellants in aerosols with zero-quota baseline reductions targeted by 2030, and by California Air Resources Board VOC limits that cap aerosol propellant and solvent volatile organic compound emissions.

India's mandatory BIS ISI Mark compliance and two-year Quality Control Order license renewals impose ongoing operational costs. The sector lacks a dedicated standalone PLI scheme, limiting government manufacturing incentive eligibility. The 18% GST structure compresses margins for smaller manufacturers.

Capital requirements for compliance with mixing technology, propellant handling safety infrastructure, and quality testing add to fixed costs. The significant unorganized segment persists as a price-competitive threat to new entrants. Consumer preference shifts toward natural and herbal products, while representing an opportunity, also require reformulation investment and may carry higher raw material costs for active botanical ingredients compared to synthetic alternatives.

Risk matrix

Category-typical risks plotted by impact and probability. Hover a numbered dot to see the risk.

Raw material price volatility: impact 2/3, probability 3/3 1 Regulatory compliance lapse: impact 3/3, probability 1/3 2 Customer concentration: impact 3/3, probability 2/3 3 Capacity utilisation shortfall: impact 2/3, probability 2/3 4 FX / import price exposure: impact 2/3, probability 2/3 5 Probability → Impact → Low Medium High High Medium Low
1. Raw material price volatility
2. Regulatory compliance lapse
3. Customer concentration
4. Capacity utilisation shortfall
5. FX / import price exposure

How to engage with KAMRIT on this report

KAMRIT offers three engagement tiers tailored to the decision stage of the project. Pick the tier that matches what you actually need: pricing, scope, and turnaround are summarised in the sidebar.

Key market drivers

  • PLI scheme allocations
  • Import substitution policy
  • Localisation under PM Gati Shakti
  • China+1 supply chain redirection
  • Export-led demand to MENA and Africa

Competitive landscape

The Indian mosquito repellent (aerosol) market is sized at ₹4,614 crore in 2026 and is on a 11.7% trajectory to ₹10,033 crore by 2033. Larsen & Toubro, Tata Steel and JSW Steel hold the leading positions , with Bharat Forge, Mahindra & Mahindra, BHEL, Cummins India also profiled in this DPR. The full report benchmarks the new entrant's CapEx (₹0.5 crore - ₹8 crore) and unit economics against the listed-peer cost structure, identifies the specific competitive gap a 3.0 - 6.0-year-payback project can exploit, and includes channel-share and pricing-position analysis. Click any name to open its live profile, current stock price, and analyst note.

Larsen & Toubro Tata Steel JSW Steel Bharat Forge Mahindra & Mahindra BHEL Cummins India

What's inside the Mosquito Repellent (Aerosol) DPR

The Mosquito Repellent (Aerosol) DPR is a 164-page PDF (Tier 2 also ships an Excel financial model) built around a small-MSME entrant assumption. It covers process flow from raw-material handling through finished-goods despatch, machinery sourcing across Indian and imported suppliers, utility load calculations, manpower per shift, and statutory environmental clearances. The financial side runs the full project economics for ₹0.5 crore - ₹8 crore CapEx: line-itemised CapEx with vendor quotes, OpEx build-up by cost head, 5-year revenue projection by SKU and channel, P&L / balance sheet / cash flow, ROI, NPV, IRR, working-capital cycle, break-even, three-scenario sensitivity, and the Means of Finance recommendation. Payback of 3.0 - 6.0 years is back-tested against the listed-peer cost structure of Larsen & Toubro and Tata Steel.

Numbers for this Mosquito Repellent (Aerosol) project

Market, operating, and project economics at a glance

A focused view of the numbers that decide this small-MSME project. The Bankable DPR breaks each of these down into the full state-by-state and vendor-by-vendor schedule.

India Aerosol Insecticide Market Size FY2026

₹4,614 crore

Consumer and B2B segments combined; household insecticide category excluding coils and mats.

Projected Market Size FY2033

₹10,033 crore

At 11.7% CAGR; 2.17x growth over 7-year period.

Projected CAGR 2026-2033

11.7%

Outpaces overall household insecticide category growth of 9.8%.

Recommended CapEx Band

₹0.5 crore - ₹8 crore

Structured for MSME to mid-size industrial capacity; payback 3.0-6.0 years.

Active Ingredient Import Dependency

65-70%

China-sourced pyrethroid technical grade; domestic formulation plants supply remaining 30-35%.

Manufacturer Level Margin

28-35%

Premium aerosol formats; compares to 18-22% for coil segment.

BIS Standard Reference

IS 3224 (2020)

Mandatory certification covering active content, net weight, spray pattern, and flammability.

Peak Season Inventory Period

October - February

4-5 month buildup cycle ahead of March-June demand; requires ₹1.8-2.2 crore peak inventory for ₹5 crore facility.

City-specific versions of this report

Setting up in your city? 20 location-specific overlays included.

Each city version of this report layers in state-specific subsidies, the local industrial land cost band, electricity tariff, distance to the nearest export port, and the closest state industrial policy headline: useful when shortlisting a location for your unit.

Table of Contents

20 chapters, 164 pages. Excel financial model included with Tier 2 and Tier 3.

Executive Summary 6 pages
Industry Overview & Market Size 14 pages
Demand & Supply Analysis 12 pages
Regulatory Framework & Licences 18 pages
Plant Setup & Location Strategy 14 pages
Manufacturing / Operating Process 16 pages
Raw Materials & Utilities 12 pages
Machinery & Equipment Specifications 18 pages
Manpower Plan & Organisation Structure 8 pages
Packaging, Branding & Distribution 10 pages
Project Cost (CapEx) & Means of Finance 14 pages
Operating Cost (OpEx) Build-Up 10 pages
Revenue Projections (5-year) 8 pages
Profitability & ROI Analysis 10 pages
Break-Even & Sensitivity Analysis 8 pages
Working Capital Requirements 6 pages
Environmental Clearance & Compliance 10 pages
Risk Assessment & Mitigation 6 pages
Competitive Landscape & Key Players 10 pages
Conclusion & Recommendations 5 pages

FAQs about this Mosquito Repellent (Aerosol) project

What is the BIS standard applicable to mosquito repellent aerosols, and what testing is mandatory for licence grant?

Mosquito repellent aerosols must comply with IS 3224 (reaffirmed 2020) which specifies parameters for active ingredient content (tested by gas chromatography), net weight accuracy (within ±2.5%), spray particle size distribution (median diameter below 50 microns for respiratory safety), and flash point (above 40°C). BIS factory audit involves sample testing from every production batch during the first six months, with reduced frequency (quarterly) after stabilisation. Licence renewal involves annual surveillance testing and factory re-audit every 18 months.

What are the active ingredients typically used in Indian mosquito repellent aerosols, and what are the import dependency risks?

The Indian aerosol market predominantly uses synthetic pyrethroids: d-allethrin (40-50% market share), prallethrin (25-30%), and transfluthrin (10-15%). Imports from China (Jiangsu Houtian, Yangnong Chemical) supply approximately 65-70% of pyrethroid technical grade active ingredient demand. Import dependency creates supply chain risk, with custom duty at 10% on technical grade pyrethroids under the Customs Tariff Act. The Atmanirbhar Bharat initiative has spurred domestic formulation plants, though captive synthesis capacity remains limited. KAMRIT recommends maintaining 90-120 days of active ingredient safety stock as risk mitigation.

What is the typical production capacity break-up for an aerosol filling line, and what is the cost per can at different utilisation levels?

A semi-automatic filling line with throughput of 35-40 cans per minute generates approximately 1.2-1.5 lakh cans monthly at single-shift operations. Full annual capacity at 90% efficiency approximates 12-15 lakh cans for a semi-automatic line and 35-45 lakh cans for a fully automatic rotary system. At a ₹5 crore plant (one semi-automatic and one automatic line), installed capacity reaches 50-55 lakh cans annually. Cost per can including material (₹18-22), conversion (₹4-6), and overhead (₹2-3) totals ₹24-31, with landed cost varying by formulation complexity and can size (150g to 400g).

What industrial cluster locations offer the best regulatory and logistics advantage for aerosol manufacturing in India?

Tarapur Industrial Area (Maharashtra) hosts the highest concentration of aerosol manufacturers in India due to established safety infrastructure, PESO presence, and proximity to Mumbai port for import of active ingredients. Pithampur (Madhya Pradesh) offers land at ₹1,800-2,200 per sq ft with state MSME incentives. Baddi (Himachal Pradesh) provides cost advantages due to ULIP zone status and low power tariffs. The choice depends on target market geography: for West and North markets, Tarapur or Pithampur; for South markets, Sriperumbudur (Tamil Nadu) or Pun (Karnataka).

How does the seasonal demand pattern impact working capital planning for aerosol manufacturers?

Mosquito repellent aerosol demand follows a pronounced summer peak, with 55-60% of annual volume concentrated in Q1 and Q2 (March-June). This creates a working capital cycle requiring inventory buildup of 4-5 months of peak season production (October-February), followed by a clearance phase during monsoon (July-September) when demand troughs. For a ₹5 crore plant, peak inventory value reaches ₹1.8-2.2 crore, requiring a dedicated working capital facility. KAMRIT recommends structuring a ₹1.5 crore CC with ₹1 crore WCDL combination to manage the seasonal draw pattern without incurring higher interest costs during the low-demand period.

What export market opportunities exist for Indian mosquito repellent aerosol manufacturers?

The India+1 supply chain redirection and PLI incentives create export pathways to MENA (Middle East and North Africa) and Sub-Saharan Africa markets where Indian brands enjoy price competitiveness and established distributor relationships. Key target markets include Saudi Arabia (market size $45 million, growing 8%), UAE ($28 million), Nigeria ($35 million), and Kenya ($18 million). Each market requires separate registration with national pesticide authorities (SFDA, MOHAP, PCPB). The RoDTEP scheme provides export incentives of 2-3% on FOB value for registered manufacturers. Export logistics require UN-certified packaging for aerosol can shipping under IMDG Class 2 classification.

Not sure which tier you need?

Senior Partner Vishal Ranjan or Associate Vidushi Kothari will take a 20-minute scoping call and recommend the right engagement tier for your decision stage. Response within one business day.